IDENTIFICATION OF OX40 LIGAND AND PRELIMINARY CHARACTERIZATION OF ITS ACTIVITIES ON OX40 RECEPTOR

被引：0
|
作者：
BAUM, PR
GAYLE, RB
RAMSDELL, F
SRINIVASAN, S
SORENSEN, RA
WATSON, ML
SELDIN, MF
CLIFFORD, KN
GRABSTEIN, K
ALDERSON, MR
GOODWIN, RG
FANSLOW, WC
机构：
[1] IMMUNEX RES & DEV CORP,DEPT MOLEC GENET,SEATTLE,WA 98101
[2] IMMUNEX RES & DEV CORP,DEPT IMMUNOBIOL,SEATTLE,WA 98101
[3] IMMUNEX RES & DEV CORP,DEPT PROT CHEM,SEATTLE,WA 98101
[4] IMMUNEX RES & DEV CORP,DEPT CELLULAR IMMUNOL,SEATTLE,WA 98101
[5] DUKE UNIV,MED CTR,DEPT MED,DIV RHEUMATOL & IMMUNOL,MOLEC GENET LAB,DURHAM,NC 27710
来源：
CIRCULATORY SHOCK | 1994年 / 44卷 / 01期
关键词：
CD4(+); T CELLS; MURINE MOLECULES; TNF/NGF RECEPTORS; CELL SURFACE ANTIGENS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：30 / 34
页数：5
相关论文
共 50 条
  • [31] OX40 and OX40L Interaction in Cancer
    Lu, Xinjie
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (28) : 5659 - 5673
  • [32] On OX40 and PD-1 Combination: Why Should OX40 Be First in Sequence?
    Colombo, Mario P.
    CLINICAL CANCER RESEARCH, 2017, 23 (20) : 5999 - 6001
  • [33] Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
    Sato, Ayaka
    Nagai, Hodaka
    Suzuki, Ayano
    Ito, Aya
    Matsuyama, Shimpei
    Shibui, Nagito
    Morita, Masashi
    Hikosaka-Kuniishi, Mari
    Ishii, Naoto
    So, Takanori
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [34] OX40/OX40 ligand interaction is critical for chronic intestinal inflammation in DSS-induced colitis in mice.
    Obermeier, F
    Schwarz, H
    Dunger, N
    Schölmerich, J
    Falk, W
    GASTROENTEROLOGY, 2002, 122 (04) : A390 - A390
  • [35] Blockade of OX40/OX40 Ligand to Decrease Cytokine messenger RNA Expression in Acute Renal Allograft Rejection In Vitro
    Wang, Y-L
    Li, G.
    Fu, Y-X.
    Wang, H.
    Shen, Z-Y
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (06) : 2565 - 2568
  • [36] Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells
    AlShamkhani, A
    Mallett, S
    Brown, MH
    James, W
    Barclay, AN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) : 5275 - 5282
  • [37] Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy
    Sani, Aliya, I
    Zil-e-Rubab
    Usman, Shumaila
    Ahmed, Syed Zaryab
    Hosein, Mervyn
    AIMS MOLECULAR SCIENCE, 2021, 8 (03): : 161 - 173
  • [38] OX40/OX40L axis: not a friend in autoimmunity
    Ueno, Hideki
    Blanco, Patrick
    ONCOTARGET, 2015, 6 (26) : 21779 - 21780
  • [39] OX40, OX40L and Autoimmunity: a Comprehensive Review
    Webb, Gwilym J.
    Hirschfield, Gideon M.
    Lane, Peter J. L.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 50 (03) : 312 - 332
  • [40] OX40 (CD134) and OX40L
    Gough, Michael J.
    Weinberg, Andrew D.
    THERAPEUTIC TARGETS OF THE TNF SUPERFAMILY, 2009, 647 : 94 - 107
12345